![General Commons Logo](./assets/images/crdc-logo.svg) 
# caNanoLab DOI 
-------------------------- 
## DOI:	Not Available 
**Protocol Name:**	NCL Method ITA-2.2  
**Protocol Abbreviation:**	ITA-2.2  
**Protocol Version:**	nan  
-------------------------- 
### Resource Type:	Protocol 
### Publication Status:	publication_status 
#### Created Date:	2017-05-03 10:48:00 
-------------------------- 
| Property | Value | 
|----------|---------| 
| Sample ID | 115900476 | 
| Sample Name | Liposomal Docetaxel (NCL280) | 
| Organization | Nanotechnology Characterization Laboratory | 
| Sample ID | 115900463 | 
| Sample Name | Liposomal bortezomib (NCL319) | 
| Organization | Nanotechnology Characterization Laboratory | 
| Sample ID | 92471313 | 
| Sample Name | Nanoemulsion + Gd + Ceramide + PTX (NCL59) | 
| Organization | Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 92471312 | 
| Sample Name | Nanoemulsion + Gd + Ceramide (NCL58) | 
| Organization | Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 92471311 | 
| Sample Name | Nanoemulsion + Gd + PTX (NCL57) | 
| Organization | Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 92471310 | 
| Sample Name | Nanoemulsion + Gd (NCL56) | 
| Organization | Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 92471309 | 
| Sample Name | Nanoemulsion (NCL55) | 
| Organization | Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 91914244 | 
| Sample Name | Layer-by-layer polymeric nanoparticles (NCL119) | 
| Organization | NCL, Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 91914243 | 
| Sample Name | Paclitaxel-loaded layer-by-layer polymeric nanoparticle (NCL113) | 
| Organization | Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 90243072 | 
| Sample Name | Dextran-Coated Iron Oxide Magnetic Nanoparticles (NCL336) | 
| Organization | NCL, Nanotechnology Characterization Laboratory, Leidos Biomedical Research Inc. | 
| Sample ID | 62652418 | 
| Sample Name | UNC_TUD_NCL_JMWU_MSSU_LMSU-ZHeBMat2016-04 | 
| Organization | UNC_CNDD; JMUW_CCTMS, Functional Polymer Materials | 
| Sample ID | 62652416 | 
| Sample Name | UNC_TUD_NCL_JMWU_MSSU_LMSU-ZHeBMat2016-02 | 
| Organization | UNC_CNDD; JMUW_CCTMS, Functional Polymer Materials | 
| Characterization ID | 115573536|115573535|115573534|115573543|115573539|115573541|115573537|115573538|115573542|115573517|115573516 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['RP-HPLC|Zeta Potential|Dynamic Light Scattering|drug release|coagulation|complement activation|hemolysis|platelet aggregation|leukocyte procoagulant activity|endotoxin|microbial contamination'] | 
| Characterization ID | 115573456|115573449|115573447|115573448|115573453|115573455|115573454|115573445|115573446|115573443|115573444|115573450|115573451|115573452|115573442|115573441 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['Free vs encapsulated BTZ|composition|Dynamic Light Scattering|Zeta Potential|Proteasome inhibition|in vitro drug release (BED)|in vitro drug release (SITUA)|Plasma coagulation time|complement activation|hemolysis|platelet aggregation|MTT & LDH|MTT & LDH|MTT & LDH|endotoxin|microbial contamination'] | 
| Characterization ID | 92602422|92602420|92602411|92602413|93519917|93519875|93519880|93519895|93519885|93519890|92602429|92602431|93519900|93519915|93519905|93519910 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vivo|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['arsenazo|ICP-OES|Dynamic Light Scattering|Zeta Potential|systemic toxicity assessment|caspase 3 activity in Hep G2 cells|caspase 3 activity in LLC-PK1 cells|complement activation|hemolysis|platelet aggregation|MTT & LDH|MTT & LDH|CFU-GM|chemotaxis|leukocyte proliferation|nitric oxide'] | 
| Characterization ID | 92602424|92602419|92602410|92602416|93519874|93519879|93519894|93519884|93519889|92602428|92602434|93519899|93519914|93519904|93519909 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['arsenazo|ICP-OES|Dynamic Light Scattering|Zeta Potential|Caspase 3 Activity Assay|Caspase 3 Activity Assay|complement activation|hemolysis|platelet aggregation|MTT & LDH|MTT & LDH|CFU-GM|chemotaxis|leukocyte proliferation|nitric oxide'] | 
| Characterization ID | 92602425|92602421|92602412|92602417|93519876|93519881|93519896|93519886|93519891|92602430|92602435|93519901|93519916|93519906|93519911 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['arsenazo|ICP-OES|Dynamic Light Scattering|Zeta Potential|Caspase 3 Activity Assay|Caspase 3 Activity Assay|complement activation|hemolysis|platelet aggregation|MTT & LDH|MTT & LDH|CFU-GM|chemotaxis|leukocyte proliferation|nitric oxide'] | 
| Characterization ID | 92602423|92602418|92602409|92602415|93519873|93519878|93519893|93519883|93519888|92602426|92602433|93519898|93519913|93519903|93519908 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['arsenazo|ICP-OES|Dynamic Light Scattering|Zeta Potential|Caspase 3 Activity Assay|Caspase 3 Activity Assay|complement activation|hemolysis|platelet aggregation|MTT & LDH|MTT & LDH|CFU-GM|chemotaxis|leukocyte proliferation|nitric oxide'] | 
| Characterization ID | 92602408|92602414|93519872|93519877|93519892|93519882|93519887|92602427|92602432|93519897|93519912|93519902|93519907 | 
| Characterization Type | physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['Dynamic Light Scattering|Zeta Potential|Caspase 3 Activity Assay|Caspase 3 Activity Assay|complement activation|hemolysis|platelet aggregation|MTT & LDH|MTT & LDH|CFU-GM|chemotaxis|leukocyte proliferation|nitric oxide'] | 
| Characterization ID | 92078085|92078086|92078098|92078094|92078096|92078090|92078092|92078081|92078083 | 
| Characterization Type | physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['Dynamic Light Scattering|Zeta Potential|complement activation|hemolysis|platelet aggregation|MTT|MTT|bacterial/yeast/mold|endotoxin'] | 
| Characterization ID | 92078088|92078084|92078087|92078097|92078093|92078095|92078089|92078091|92078080|92078082 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['RP-HPLC|Dynamic Light Scattering|Zeta Potential|complement activation|hemolysis|platelet aggregation|MTT|MTT|bacterial/yeast/mold|endotoxin'] | 
| Characterization ID | 90800147|90800150|90210305|90210307|90800153|90800154|90800151|90800152|91291648 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['Concentration|Concentration|Diameter|surface chemistry|coagulation|complement activation|hemolysis|platelet aggregation|cytokine induction'] | 
| Characterization ID | 62750760|62750761|62750762|62750763|62750769|63143967|62750771|62750750|62750751|62750754|65863692|62750749|63143956|63143949|63143948|63143950|63143951|63143952|63143953|63143955|63143945|63143947|63143943|63143942|63143946|63143939|63143936|63143937|63143938|63143940|63143941 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|ex vivo|in vivo|in vivo|in vivo|in vivo|in vivo|in vivo|in vivo|in vivo|in vivo|in vivo|in vivo|in vivo|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['drug concentration|drug loading capacity|drug loading efficiency|drug release|fluorescence quenching|morphology|protein binding|stability|stability|stability|size|surface|histology|biodistribution|therapeutic efficacy|therapeutic efficacy|therapeutic efficacy|therapeutic efficacy|therapeutic efficacy|therapeutic efficacy|pharmacokinetics|pharmacokinetics|toxicity|toxicity|toxicity|coagulation|complement activation|hemolysis|platelet aggregation|cell viability|cell viability'] | 
| Characterization ID | 62750734|62750723|62750724|62750725|62750726|62750727|65863690|62750720|62750742|62750740|63143944|65863691|62750735|62750736|62750737|62750738|62750739 | 
| Characterization Type | physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|physico-chemical|ex vivo|in vivo|in vivo|in vitro|in vitro|in vitro|in vitro|in vitro|in vitro | 
| Assay Type | ['fluorescence quenching|stability|stability|stability|stability|stability|size|surface|histology|toxicity|toxicity|coagulation|complement activation|hemolysis|platelet aggregation|cell viability|cell viability'] | 
| Nanomaterial Entity Type | liposome | 
| Nanomaterial Entity Type | liposome | 
| Nanomaterial Entity Type | emulsion | 
| Nanomaterial Entity Type | emulsion | 
| Nanomaterial Entity Type | emulsion | 
| Nanomaterial Entity Type | emulsion | 
| Nanomaterial Entity Type | emulsion | 
| Nanomaterial Entity Type | polymer | 
| Nanomaterial Entity Type | polymer | 
| Nanomaterial Entity Type | iron oxide nanoparticles | 
| Nanomaterial Entity Type | polymer | 
| Nanomaterial Entity Type | polymer | 
| Protocol ID | 62947328 | 
| Protocol Type | in vitro assay | 
| Protocol Name |NCL Method ITA-2.2 | 
| Composing Element Type | composing_element_type | 
| Composing Element Chemical Name | composing_element_chemical_name | 
| File Name | protocols/20191127_12-50-42-520_NCL_Method_ITA-2.2.pdf | 
| File URI | protocols/20191127_12-50-42-520_NCL_Method_ITA-2.2.pdf | 
| Nanomaterial Entity File Type | nanomaterial_entity_file_type | 
| Chemical Association File Type Title | chemical_association_file_type_title | 
